• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION WAVEWRITER ALPHA PRIME; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION WAVEWRITER ALPHA PRIME; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF Back to Search Results
Model Number SC-1432
Device Problems Premature Discharge of Battery (1057); Unexpected Therapeutic Results (1631); Battery Problem (2885); Wireless Communication Problem (3283)
Patient Problem Inadequate Pain Relief (2388)
Event Date 08/10/2021
Event Type  Injury  
Manufacturer Narrative
Approximated based on the date the manufacturer became aware of the event.Additional suspect medical device component involved in the event: product family: scs-paddle leads, upn: m365sc8352500, model: sc-8352-50, serial: (b)(4), batch: 2000014780.
 
Event Description
It was reported that the patient was not getting an adequate stimulation coverage.It was also noted that the ipg was nonfunctional and was having communication issues.The patient underwent spinal cord stimulator (scs) system replacement procedure and was doing well post operatively.
 
Manufacturer Narrative
Sc-1432 (sn: (b)(6)) the returned ipg was analyzed.Upon receiving, the device exhibits the eri (elective replacement indicator).The battery voltages were 2.749 volts by yack above the expressed eri threshold voltage.Eri will appear when the device battery level is below the expected range of 2.65 volts and will suspend normal operation with the end-of-service message.Lab analysis of the device did not reveal any anomalies.The energy use index (eui) for the settings was 100 and its estimated longevity is about 4-5 months.This device has generated an early eri message before the battery reaches below 2.65 volts (2.747 volts vs 2.65 volts).With all the available information, boston scientific concludes that the complaint was not confirmed.Sc-8352-50 (sn: (b)(6)) the returned lead was analyzed.A visual inspection found the lead was cleanly cut.No anomalies were identified on the lead aside from the clean-cut.The damage to the lead is a result of a typical explant procedure, and it is not considered a failure.
 
Event Description
It was reported that the patient was not getting an adequate stimulation coverage.It was also noted that the ipg was nonfunctional and was having communication issues.The patient underwent spinal cord stimulator (scs) system replacement procedure and was doing well post operatively.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WAVEWRITER ALPHA PRIME
Type of Device
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key12520051
MDR Text Key272937004
Report Number3006630150-2021-05334
Device Sequence Number1
Product Code LGW
UDI-Device Identifier08714729985075
UDI-Public08714729985075
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/19/2022
Device Model NumberSC-1432
Device Catalogue NumberSC-1432
Device Lot Number201665
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/08/2021
Date Manufacturer Received09/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-